Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 268

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Targeting Autophagy in Aging and Aging-Related Cardiovascular Diseases

Open access
Ren, Jun, Zhang, Yingmei·2018·Trends in Pharmacological Sciences

Abstract

Aging, an irreversible biological process, serves as an independent risk factor for chronic disease including cancer, pulmonary, neurodegenerative and cardiovascular diseases. In particular, high morbidity and mortality has been associated with cardiovascular aging although effective clinical therapeutic remedy is suboptimal for the ever-rising aging population. Recent evidence suggests a unique role for aberrant aggregate clearance and protein quality control machinery - the process of autophagy in shortened lifespan, compromised healthspan, onset and development of aging-associated cardiovascular diseases. Autophagy degrades and removes long-lived or damaged cellular organelles and proteins, the functions of which decline with advanced aging. Induction of autophagy using rapamycin, resveratrol, nicotinamide derivatives, metformin, urolithin A and spermidine delays aging, prolongs lifespan and improves cardiovascular function in aging. Given the ever-rising human lifespan and aging population as well as the prevalence of cardiovascular disease provoked with increased age, it is pertinent to understand the contribution and underlying mechanisms for autophagy and organelle-selective autophagy (e.g., mitophagy) in the regulation of lifespan, healthspan and cardiovascular aging. Here we will dissect the mechanism of action for autophagy failure in aging and discuss the potential rationale of targeting autophagy using pharmacological agents as new avenues in the combat of biological and cardiovascular aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tips.2018.10.005

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 97 references

Cited by

Metadata

Authors
Ren, J., & Zhang, Y.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2018-12
Volume
39
Issue
12
Pages
1064-1076
ISSN
0165-6147 (ISSN-L)
OpenAlex
W2898520486
Cited by
268
References
97
FWCI
4.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.